Clinical trials · Austin, TX
Neovascular Age-Related Macular Degeneration (nAMD) clinical trials in Austin
We’re tracking 7 recruiting neovascular age-related macular degeneration (namd) studies with a site in or near Austin — including Phase 3 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies near Austin
- NCT07482176RecruitingPhase 3
Gene therapy trial for wet age-related macular degeneration
This trial tests a one-time gene therapy injection (IXO-vec) for people with wet age-related macular degeneration (nAMD). It aims to reduce the need for frequent eye injections by helping the eye make its own medicine to block the growth of harmful blood vessels.
Austin, TexasAges 50 years+ - NCT04853251RecruitingPhase 4
Study of corneal cells after a ranibizumab eye implant
This trial checks how well corneal endothelial cells (cells that help keep the cornea clear) do in people with neovascular age-related macular degeneration (nAMD) who are treated with a port-delivery implant that releases ranibizumab. It also helps doctors understand whether this method changes corneal health and stays safe while controlling the eye disease.
Austin, TexasAges 50 years+ - NCT07007065RecruitingPhase 3
Study of a gene therapy for wet age-related macular degeneration
This trial tests a one-time gene therapy injection for wet AMD that may reduce the need for regular eye injections. It is for people who have already responded to anti-VEGF injections but want a longer-lasting treatment.
Austin, TexasAges 50 years+ - NCT03683251RecruitingPhase 3
Extension study for a refillable eye implant plus ranibizumab
This trial studies whether continuing treatment with a refillable eye implant (Port Delivery System) and ranibizumab injection helps control a specific type of wet macular degeneration. It’s mainly for people who already finished an earlier related study and are able to keep up with frequent eye checks and procedures.
Austin, TexasAges 50 years+ - NCT07516132RecruitingPhase 3
Long-term safety study of axitinib implant for wet macular degeneration
This study follows people who completed an earlier 2-year trial of OTX-TKI, a small implant placed in the eye to treat wet age-related macular degeneration (a condition causing vision loss). Researchers want to make sure the treatment remains safe over time.
Austin, TexasAges 50 years+ - NCT07614776RecruitingPhase 3
New Eye Injection Treatment for Age-Related Macular Degeneration
This study tests whether a new eye injection called ABP 938 works as well as or better than the current standard treatment (Eylea) for wet age-related macular degeneration—a condition that causes vision loss in the center of your sight. You would receive injections into your eye every month for a year.
Austin, TexasAges 50 years+ - NCT07064759RecruitingPhase 3
Gene therapy injection for wet age-related macular degeneration
This trial tests a one-time gene therapy injection (4D-150) for wet AMD. It might help reduce the need for frequent anti-VEGF eye injections by targeting the underlying cause of new blood vessel growth.
Austin, TexasAges 50 years+
Hear when a new Neovascular Age-Related Macular Degeneration (nAMD) trial opens near Austin, TX
We’ll email you when one opens near Austin, TX — at most once a week, no account needed, unsubscribe anytime.
Neovascular Age-Related Macular Degeneration (nAMD) trials in other cities
Where these studies are running near Austin
Institutions with a site for the recruiting neovascular age-related macular degeneration (namd) studies listed above.
- Austin Retina Associates · 5 studies
- Austin Clinical Research, LLC · 4 studies
- Adverum Clinical Site 232
- Clinical Site
What taking part in a neovascular age-related macular degeneration (namd) study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting neovascular age-related macular degeneration (namd) studies in Texas.
Common questions
- Are there neovascular age-related macular degeneration (namd) clinical trials near Austin?
- Yes. We're currently tracking 7 recruiting neovascular age-related macular degeneration (namd) studies with a site near Austin, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a neovascular age-related macular degeneration (namd) study near Austin?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Austin to take part?
- Not necessarily. These studies have a site near Austin, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a neovascular age-related macular degeneration (namd) trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New neovascular age-related macular degeneration (namd) studies open near Austin regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.